Unveiling of the new logo from Euroimmun
Company

What you know and trust – soon with a new shine

Euroimmun is modernizing its brand appearance Our company has undergone significant developments in recent years. This will now also be reflected in our visual appearance. At the ADLM in Chicago (July 27–31, 2025), we will show you our new, modernized look for the first time, underlining our innovative power and our international orientation. But, of […]

Company

Two companies, one goal

SARS-CoV-2, the bird flu A(H7N9), MPox – several new and worrying diseases have appeared over the past years which are a great challenge to public health. In order to protect the population, the responsible health authorities have a range of measures at hand to fight and prevent epidemics. Besides the development of vaccines and medications,

Company

Revvity’s EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to Expand CE-IVD Molecular Assay Offerings

Press release Lübeck, 25 April 2024 Revvity’s EUROIMMUN business, a leading provider of high-quality in-vitro diagnostic products, and ALPCO-GeneProof, a global leader in molecular diagnostics, jointly announced a strategic partnership to enhance the availability of GeneProof PCR kits throughout the European Union. This collaboration brings together EUROIMMUN’s extensive distribution network and support infrastructure with ALPCO-GeneProof’s

Company

Supporting Ukrainian refugees in Poland

At the end of March 2022, the German Health Ministers’ Conference dealt with the topic of “vaccinations and medical care for Ukrainian refugees,” due to seemingly large vaccination gaps among the Ukrainian population and the circumstances under which refugees often initially live – many people in a small space with comparatively poor hygienic conditions. These

Scroll to Top